Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123345232 | 12334523 | 2 | F | 20160712 | 20160504 | 20160721 | PER | US-PFIZER INC-2016137069 | PFIZER | 77.00 | YR | F | Y | 73.00000 | KG | 20160721 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123345232 | 12334523 | 1 | PS | AROMASIN | EXEMESTANE | 1 | Oral | 25 MG, DAILY | Y | 20753 | 25 | MG | COATED TABLET | ||||||
| 123345232 | 12334523 | 2 | SS | AROMASIN | EXEMESTANE | 1 | Y | 20753 | COATED TABLET | ||||||||||
| 123345232 | 12334523 | 3 | C | AMLODIPINE BESYLATE. | AMLODIPINE BESYLATE | 1 | Oral | 10 MG, DAILY | 0 | 10 | MG | TABLET | |||||||
| 123345232 | 12334523 | 4 | C | CARVEDILOL. | CARVEDILOL | 1 | Oral | 25 MG, 2X/DAY | 0 | 25 | MG | TABLET | BID | ||||||
| 123345232 | 12334523 | 5 | C | COENZYME Q10 | UBIDECARENONE | 1 | Oral | 200 MG, DAILY | 0 | 200 | MG | CAPSULE | |||||||
| 123345232 | 12334523 | 6 | C | FENOFIBRIC ACID. | FENOFIBRIC ACID | 1 | Oral | 135 MG, DAILY | 0 | 135 | MG | MODIFIED-RELEASE CAPSULE, HARD | |||||||
| 123345232 | 12334523 | 7 | C | FERROUS SULFATE. | FERROUS SULFATE | 1 | Oral | 325 MG, DAILY | 0 | 325 | MG | TABLET | |||||||
| 123345232 | 12334523 | 8 | C | GABAPENTIN. | GABAPENTIN | 1 | Oral | 300 MG, 3X/DAY | 0 | 300 | MG | CAPSULE | TID | ||||||
| 123345232 | 12334523 | 9 | C | GARLIC. | GARLIC | 1 | Oral | 1000 MG, DAILY | 0 | 1000 | MG | CAPSULE | |||||||
| 123345232 | 12334523 | 10 | C | GLYBURIDE. | GLYBURIDE | 1 | Oral | 10 MG, 1X/DAY (5MG 2 TABLET EVERY AM) | 0 | 10 | MG | TABLET | QD | ||||||
| 123345232 | 12334523 | 11 | C | GLYBURIDE. | GLYBURIDE | 1 | Oral | 5 MG, 1X/DAY (5MG TBALET PO PM) | 0 | 5 | MG | TABLET | QD | ||||||
| 123345232 | 12334523 | 12 | C | LANTUS | INSULIN GLARGINE | 1 | Subcutaneous | UNK, 1X/DAY (20 UNITS (OF 100 UNITS/ML) SUBCUTANEOUS AT BEDTIME) | 0 | SOLUTION FOR INJECTION | QD | ||||||||
| 123345232 | 12334523 | 13 | C | OXYBUTYNIN CHLORIDE. | OXYBUTYNIN CHLORIDE | 1 | Oral | 20 MG, 1X/DAY | 0 | 20 | MG | PROLONGED-RELEASE TABLET | QD | ||||||
| 123345232 | 12334523 | 14 | C | PRILOSEC | OMEPRAZOLE MAGNESIUM | 1 | Oral | 20 MG, DAILY | 0 | 20 | MG | MODIFIED-RELEASE CAPSULE, HARD | |||||||
| 123345232 | 12334523 | 15 | C | SUPER VITAMIN B COMPLEX | 2 | Oral | 1 DF, DAILY | 0 | 1 | DF | TABLET | ||||||||
| 123345232 | 12334523 | 16 | C | VITAMIN B12 | CYANOCOBALAMIN | 1 | Oral | 1000 UG, DAILY | 0 | 1000 | UG | TABLET | |||||||
| 123345232 | 12334523 | 17 | C | VITAMIN D3 | CHOLECALCIFEROL | 1 | Oral | 1000 IU, 2X/DAY (1000 UNITS) | 0 | 1000 | IU | CAPSULE | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123345232 | 12334523 | 1 | Breast cancer |
| 123345232 | 12334523 | 2 | Lobular breast carcinoma in situ |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123345232 | 12334523 | Arthritis | |
| 123345232 | 12334523 | Condition aggravated | |
| 123345232 | 12334523 | Constipation | |
| 123345232 | 12334523 | Cough | |
| 123345232 | 12334523 | Diarrhoea | |
| 123345232 | 12334523 | Dry mouth | |
| 123345232 | 12334523 | Eye swelling | |
| 123345232 | 12334523 | Fatigue | |
| 123345232 | 12334523 | Headache | |
| 123345232 | 12334523 | Hot flush | |
| 123345232 | 12334523 | Hypersensitivity | |
| 123345232 | 12334523 | Lip swelling | |
| 123345232 | 12334523 | Neuropathy peripheral | |
| 123345232 | 12334523 | Pain | |
| 123345232 | 12334523 | Pruritus | |
| 123345232 | 12334523 | Rash erythematous | |
| 123345232 | 12334523 | Swelling | |
| 123345232 | 12334523 | Upper respiratory tract infection | |
| 123345232 | 12334523 | Urinary incontinence |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 123345232 | 12334523 | 1 | 20160203 | 201603 | 0 | |
| 123345232 | 12334523 | 12 | 20151028 | 0 |